News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Therapeuticsmd Inc
(NQ:
TXMD
)
1.840
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.840
Bid (Size)
1.650 (1)
Ask (Size)
1.980 (1)
Prev. Close
1.840
Today's Range
1.840 - 1.840
52wk Range
1.430 - 4.350
Shares Outstanding
9,953,290
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023
June 28, 2024
TherapeuticsMD just reported results for the fourth quarter of 2023.
Via
InvestorPlace
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
May 10, 2024
TherapeuticsMD just reported results for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-21.03%
-21.03%
1 Month
-4.17%
-4.17%
3 Month
-2.13%
-2.13%
6 Month
-17.86%
-17.86%
1 Year
-55.56%
-55.56%
More News
Read More
TherapeuticsMD Announces First Quarter 2024 Financial Results
May 10, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Full Year 2023 Financial Results
March 29, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
March 04, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
June 05, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
December 25, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
November 27, 2023
Via
Benzinga
TherapeuticsMD Announces Third Quarter 2023 Financial Results
November 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
Nasdaq Jumps 100 Points; US Trade Deficit Widens In September
November 07, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
TherapeuticsMD Announces Second Quarter 2023 Financial Results
August 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
TherapeuticsMD Announces First Quarter 2023 Financial Results
May 15, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
April 07, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 23, 2023
Via
InvestorPlace
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
January 03, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 05, 2022
Via
Benzinga
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
December 04, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Third Quarter 2022 Financial Results
November 14, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Additional $7 Million Private Placement
October 31, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces $7 Million Private Placement
October 03, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
Via
Benzinga
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
September 12, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.